PKCθ: A new target for selective immunosuppression

Expert Review of Clinical Immunology

Volumn 8, Issue 3, 2012, Pages 205-208

  Altman, Amnon ^a   Kong, Kok Fai ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

allergy; autoimmunity; immunosupression; kinase inhibitor; PKC ; T cell; transplantation

Indexed keywords

CD28 ANTIGEN; CYCLOSPORIN A; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C THETA; SOTRASTAURIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ALLERGY; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNITY; CALCIUM SIGNALING; CELIAC DISEASE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CLONAL ANERGY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG TARGETING; ENZYME ANALYSIS; GAIN OF FUNCTION MUTATION; GENE LOCUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO CULTURE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MONOTHERAPY; NONHUMAN; ONCOGENE C KIT; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; THYMUS;

ANIMALS; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; ISOENZYMES; MICE; MICE, KNOCKOUT; MOLECULAR TARGETED THERAPY; NF-KAPPA B; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PSORIASIS; PYRROLES; QUINAZOLINES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84858435101     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.8     Document Type: Review

References (25)

1. Baier G, Telford D, Giampa L et al. Molecular cloning and characterization of PKCq, a human novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 268, 4997-5004 (1993).
2. Hayashi K, Altman A. Protein kinase C q (PKCq): A key player in T cell life and death. Pharmacol. Res. 55, 537-544 (2007).
3. Sun Z, Arendt CW, Ellmeier W et al. PKC-q is required for TCR-induced NF-kB activation in mature but not immature T lymphocytes. Nature 404, 402-407 (2000).
4. Pfeifhofer C, Gruber T, Letschka T et al. Defective IgG2a/2b class switching in PKC a-/- mice. J. Immunol. 176, 6004-6011 (2006).
5. Berg-Brown NN, Gronski MA, Jones RG et al. PKCq signals activation versus tolerance in vivo. J. Exp. Med. 199, 743-752 (2004).
6. Fu G, Hu J, Niederberger-Magnenat N et al. Protein Kinase C h is required for T cell activation and homeostatic proliferation. Sci. Signal. 4, ra84 (2011).
7. Marsland BJ, Kopf M. T-cell fate and function: PKC-q and beyond. Trends Immunol. 29, 179-185 (2008).
8. Valenzuela JO, Iclozan C, Hossain MS et al. PKCq is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J. Clin. Invest. 119, 3774-3786 (2009).
9. Marsland BJ, Nembrini C, Grun K et al. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-q signaling and promote autoimmune myocarditis. J. Immunol. 178, 3466-3473 (2007).
10. Coenen MJ, Trynka G, Heskamp S et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet. 18, 4195-4203 (2009).
11. Cooper JD, Smyth DJ, Smiles AM et al. Meta-analysis of genome-wide association study data identifies additional Type 1 diabetes risk loci. Nat. Genet. 40, 1399-1401 (2008).
12. Blay P, Astudillo A, Buesa JM et al. Protein kinase C q is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin. Cancer Res. 10, 4089-4095 (2004).
13. Baier G, Wagner J. PKC inhibitors: Potential in T cell-dependent immune diseases. Curr. Opin. Cell Biol. 21, 262-267 (2009).
14. Cywin CL, Dahmann G, Prokopowicz AS 3rd et al. Discovery of potent and selective PKC-q inhibitors. Bioorg. Med. Chem. Lett. 17, 225-230 (2007).
15. Mosyak L, Xu Z, Joseph-McCarthy D, Brooijmans N, Somers W, Chaudhary D. Structure-based optimization of PKCq inhibitors. Biochem. Soc. Trans. 35, 1027-1031 (2007).
16. Friman S, Arns W, Nashan B et al. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: Randomized Phase II study in renal transplant recipients. Am. J. Transplant. 11, 1444-1455 (2011).
17. Skvara H, Dawid M, Kleyn E et al. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J. Clin. Invest. 118, 3151-3159 (2008).
18. Evenou JP, Wagner J, Zenke G et al. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J. Pharmacol. Exp. Ther. 330, 792-801 (2009).
19. Matz M, Weber W, Mashreghi MF et al. Effects of the new immunosuppressive agent AEB071 on human immune cells. Nephrol. Dial. Transplant. 25, 2159-2167 (2010).
20. Weckbecker G, Pally C, Beerli C et al. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720. Transpl. Int. 23, 543-552 (2010).
21. Gruber T, Hermann-Kleiter N, Pfeifhofer-Obermair C et al. PKC q cooperates with PKC q in alloimmune responses of T cells in vivo. Mol. Immunol. 46, 2071-2079 (2009).
22. Grakoui A, Bromley SK, Sumen C et al. The immunological synapse: A molecular machine controlling T cell activation. Science 285, 221-227 (1999).
23. Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-q during T-cell activation. Nature 385, 83-86 (1997).
24. Kong K-F, Yokosuka T, Canonigo-Balancio AJ, Isakov N, Saito T, Altman A. A motif in the V3 domain of the kinase PKC-q determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol. 12, 1105-1112 (2011).
25. Zanin-Zhorov A, Ding Y, Kumari S et al. Protein kinase C-q mediates negative feedback on regulatory T cell function. Science 328, 372-376 (2010).